drugset / Trial / NCT06893081

A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)

NCT06893081

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to learn what happens to MK-8527 in a healthy person's body over time when MK-8527 is given alone and with the medication CBZ.

Timeline

Start
2025-04-28
Primary completion
2025-06-19
Completion
2025-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule Oral
Subject MK-8527 Small molecule Oral

Indications

No indication recorded.